dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, January 25th--Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

Canadian resident pleads guilty in US health care scam Sold device under false pretense of treating more than 200 diseases

FDA gives nod to MR-conditional labeling for Abbott ICD and CRT-D Labeling will reduce anxiety for patients who need scanning

Corindus and Mayo Clinic partner to study telestenting Can the CorPath GRX enable more patients to undergo PCI?

Alex Gorsky The American Heart Association names Johnson & Johnson Chairman & CEO as chairman of its CEO roundtable

Personalized medicine: The future of cardiology New technologies are improving cardiac care

Corindus announces first commercial installation of its CorPath GRX System outside U.S. Apex Heart Institute is the pioneer in India

Physicians halt life-threatening arrhythmias with stereotactic radiation First entirely noninvasive process proposed for treating ventricular tachycardia

Researchers develop new contrast agent for better MR detection of heart disease Reveals inflamed areas in resulting scans

Hitachi and Partners Connected Health assess readmission for heart failure with AI Assesses risk of readmission within the first 30 days following release

Researchers develop AI system to better detect risk of cancer in high-risk lesions Could reduce false positives and unnecessary surgeries

Call to action for physicians

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia

by Lauren Dubinsky , Senior Reporter
The American Heart Association, the American College of Cardiology and the Heart Rhythm Society issued updated guidelines on Wednesday that recommend the use of subcutaneous implantable cardioverter-defibrillators to treat patients with ventricular arrhythmia.

“The pace of technologic innovation and the accumulation of new clinical evidence is remarkably rapid in this field,” Dr. Kenneth Stein, senior VP and CMO of rhythm management and global health policy at Boston Scientific, told HCB News. “The revised recommendations incorporate new clinical data and real-world evidence gathered since the prior guideline publication in 2006.”

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



That includes findings from the EFFORTLESS U.S. postmarket approval study published in the August issue of the Journal of the American College of Cardiology and a recent meta-analysis published in September in JACC: Clinical Electrophysiology.

Boston Scientific’s EMBLEM MRI S-ICD System is currently the only S-ICD on the market and the only implantable defibrillator that protects patients at risk of sudden cardiac death without touching the heart.

The new guidelines support the use of an S-ICD device for all patients who meet the criteria for an ICD without a need for pacing. The guidelines also strongly recommend the use of an S-ICD device as the standard of care for patients who have inadequate vascular access or are at high risk for infection including those with diabetes.

As is the case with any new therapy, physicians seek procedural experience and long-term clinical data before recommending a newer device for patients who could otherwise be treated with the prior standard of care. Stein views these recommendations as a call to action for physicians to include the S-ICD System when making treatment decisions with their ICD-indicated patients.

“The new guidelines, coupled with the most recent long-term clinical and real-world outcome data, provide further confirmation that the S-ICD System can and should be considered as a first-line therapy for those ICD-indicated patients without a pacing indication,” he added.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED